HIGHLIGHTS OF PRESCRIBING INFORMATION

These highlights do not include all the information needed to use zolpidem tartrate tablets safely and effectively. See full prescribing information for zolpidem tartrate tablets
Zolpidem tartrate tablets CIV

Initial U.S. Approval: 1992

RECENT MAJOR CHANGES

Indications and Usage ( ) 03/2007 1

Warnings and Precautions Severe anaphylactic and anaphylactoid reactions ( ) 03/2007 Abnormal thinking and behavioral changes ( ) 03/2007 Special populations ( ) 03/2007
5.2

Tags：

责任编辑：admin

【大中小】【打印】【繁体】【投稿】【收藏】【推荐】【举报】【评论】【关闭】【返回顶部】

分享到:

上一篇：Tafinlar

下一篇：PERJETA(帕妥珠单抗静脉滴注液，P..

相关栏目

Greece[希腊药品]	Belgium 比利时药品
Basic Ointments	Norway
holland[荷兰药品]	Turkey
Anti-Inflammatory	Schweiz[瑞士药品]
Homeopathic	Hungary（匈牙利药品）
Finland（芬兰）	Taiwan
Denmark[丹麦药品]	Vitamin
United Kingdom[英国药品]	Sweden[瑞典药品]
Portugal[葡萄牙药品]	Antibacterials
Thailand	China
Russia[俄罗斯药品]	Miscellaneous
Dental and Oral	Herbs and Natural Products
Antiallergic Agents	India
Germany[德国药品]	Japan[日本药品]
Lithuania	British
Italy[意大利药品]	South Korea[韩国药品]
France[法国药品]	Ireland[爱尔兰药品]
Medical Devices	Spain[西班牙药品]
America[美国药品]	South Africa[南非药品]
Slovakia[斯洛伐克药品]	Hong Kong[香港药品]
Norway[挪威药品]	Romania[罗马尼亚药品]
European Community	Australia[澳大利亚药品]
Antipruritics and	Antivirals
Canada[加拿大药品]